Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis

Lauren K. Barron, James W. Bao, Bola G. Aladegbami, Jason J. Colasanti, Jun Guo, Christopher R. Erwin, Brad W. Warner

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Background A significant number of children with short bowel syndrome experience intestinal failure-associated liver disease. We recently demonstrated accelerated hepatic steatosis after 50% small bowel resection (SBR) in mice. Since SBR is associated with alterations in the gut microbiome, the purpose of this study was to determine whether TLR4 signaling is critical to the development of resection-associated hepatic steatosis. Methods Male C57BL6 (control) and TLR4-knockout (KO) mice underwent 50% proximal SBR. Liver sections were analyzed to obtain the percent lipid content, and Ileal sections were assessed for morphological adaptation. Intestinal TLR4 mRNA expression was measured at 7 days and 10 weeks. Results Compared to controls, TLR4 KO mice demonstrated similar weight gain and morphological adaptation after SBR. Hepatic steatosis was decreased 32-fold in the absence of TLR4. Intestinal TLR4 mRNA expression was significantly elevated 7 days after SBR. We also found that TLR4 expression in the intestine was 20-fold higher in whole bowel sections compared with isolated enterocytes. Conclusions TLR4 signaling is critical for the development of resection-associated steatosis, but not involved in intestinal adaptation after massive SBR. Further studies are needed to delineate the mechanism for TLR4 signaling in the genesis of resection-associated liver injury. Level of evidence Animal study, not clinical.

Original languageEnglish
Pages (from-to)1014-1019
Number of pages6
JournalJournal of Pediatric Surgery
Volume52
Issue number6
DOIs
StatePublished - Jun 2017

Keywords

  • IFALD
  • Short bowel syndrome
  • Steatosis
  • TLR4

Fingerprint Dive into the research topics of 'Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis'. Together they form a unique fingerprint.

  • Cite this